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Human complement components C5 and C3 were purified with 41% and 20% yields, respectively, by 
euglobulin precipitation, DEAE-Sephacel ion-exchange chromatography and gel filtration. Phenyl-Se- 
pharose chromatography allowed the complete separation of C3 and C5. C3 bound loosely on the resin 
whereas C5 bound firmly and was eluted with 50% glycerin solution. Gel filtration on Sephacryl S-300 
allowed the depletion of C4bp and H that contaminated C5 preparations. Homogeneity of C5 and C3 
preparations was demonstrated by SDS-PAGE and immunochemical analysis. C5 and C3 consisted of two 
chains (cu, 110000; p, 75000) linked by disulfide bridges. 
Complement components C5 and C3 Purification Affinity chromatography, hydrophobic 
Phenyl-Sepharose Native C3 Separation of CS 
1. INTRODUCTION 
Purification of human complement components 
C3 and CS is now well established [l-5], but the re- 
cent knowledge of some structure features of C3 
molecule (i.e., presence of thiolester bond that 
could be easily hydrolyzed, leading to inactivated 
form of the molecule [6]) has pointed out the 
necessity to introduce further purification steps to 
eliminate inactivated products [6,7]. These new 
steps of purification decrease the recovery of the 
native protein and are time consuming. Here, we 
present fast procedures for the purification of 
human C5 and C3, using hydrophobic chromato- 
Abbreviations: EDTA, ethylene-diamine-tetraacetic 
acid; cACA, e-amino-caproic acid; SDS-PAGE, sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis 
Nomenclature: components of complement are those Immuno-electrophoresis and immunodiffusion 
recommended by World Health Organization (1982) were done on microscopic slides covered with 1.3% 
Eur. J. Immunol. 668-669. Agar Noble (Difco) in 0.05 M Verona1 buffer (pH 
graphy. Phenyl-Sepharose affinity chromato- 
graphy permitted the complete separation of C3 
and C5 and the recovery of pure native C3 thus 
eliminating further purification steps. Phenyl- 
Sepharose replaces advantageously the hydroxy- 
lapatite chromatography generally used to perform 
the separation of C5 from C3 preparations [ 1,5]. 
2. MATERIALS AND METHODS 
All the chemicals were of analytical grade. Fresh 
human serum was obtained from the Centre 
Regional de Transfusion Sanguine (Bois-Guil- 
laume) and was added with EDTA and EACA at 
0.02 M and 0.05 M final concentrations (pH 7.2), 
respectively, and was immediately used or stored 
for a short period (1 month) at - 80°C. 
Haemolytic assays of human C3 and CS were 
performed as in [8, 91. 
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8.6), using the following antisera: anti-whole hu- 
man serum (Organon Teknika), anti-C5 (Meloy), 
anti-1 (Kent), anti-C4bp (Dr Colomb, Grenoble), 
anti-C3c and anti-H (prepared in our laboratory). 
Presence of H and I in purified fractions was 
further checked by haemagglutination and inhibi- 
tion of immune adherence respectively, using EA 
Cl423 cells and O+ human red cells. 
Homogeneity of purified proteins was assessed 
by SDS-PAGE [lo] using 5% (w/v) acrylamide gel 
for non-reduced samples and 7.5% (w/v) 
acrylamide gel for reduced samples. Reduction of 
samples was made by 5% (v/v) ,&mercaptoetha- 
nol. 
C3 and C5 were quantified by radial immunodif- 
fusion using C3c partigen (Institut Behring) and 
anti-C5 immunodiffusion plates (Meloy) according 
to the manufacturer’s instructions. 
3. RESULTS 
3.1. Purification of C3/C5 
3.1.1. Euglobulin precipitation 
Human serum treated with inhibitors (500 ml) 
was dialyzed twice against 10 1 of 8 mM EDTA, 
pH 5.3 at 4°C. The precipitate was recovered by 
centrifugation at 8000 rev./min and washed twice 
by cold 8 mM EDTA (pH 5.3). The precipitate was 
redissolved in l/5 of the starting volume of 0.15 M 
NaCl, 0.02 M EDTA, 0.05 M 6ACA (pH 7.2). 
fT 1 I I I , ,*lw5 
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Fig. 1. Elution of complement components C3 and CS 
from DEAE-cellulose: (M) C5 haemolytic activity; 
(G--G) C3 haemolytic activity; (- ) h80; (---I 
[NaCl] . 
3.1.2. DEAE-cellulose ion-exchange 
chromatography 
The euglobulin fraction was diluted by adding 
distilled water to lower the conductivity to 3 mO 
(20°C) and applied onto a DEAE-Sephacel (Phar- 
macia) column chromatography (70 cm x 2.6 cm) 
equilibrated with 0.005 M Tris, 0.005 M EDTA, 
0.01 M cACA (pH 7.3). The column was washed 
with the equilibrating buffer until A280 was null. 
Then, elution was carried out with a gradient of 
NaCl (O-O.25 M) presenting two linear steps (gra- 
dient Former, Gilson). In a typical experiment, 2 1 
of NaCl gradient were run through the column. 
Fractions of 10 ml were collected. Elution of pro- 
teins was monitored by the measure of A280 and 
elution of C3 and C5 was observed by haemolytic 
assays of C3 and C5 in the fractions (fig. 1). C5 
eluted at a conductivity of 5 mO before C3 which 
appeared at a conductivity of 7 mQ, but the two 
proteins partially overlapped. CS-rich, C3-poor 
fractions were pooled as indicated (pool 1) and 
were immediately used for the purification of C5. 
CS-rich, CS-poor fractions were pooled (pool 2), 
concentrated and stored at - 80°C until used for 
C3 purification. 
3.2. Purification of C.5 
3.2.1. Hydrophobic affinity chromatography 
The CS-rich, C3-poor fraction (pool 1) was 
directly loaded on a phenyl-Sepharose (Phar- 
macia) column chromatography (30 cm x 2.6 cm) 
equilibrated with 0.15 M NaCl, 0.02 M EDTA and 
0.05 M 6ACA (pH 7.2). C5 bound firmly to the 
column whereas the major part of the contaminant 
was eliminated on the breakthrough peak of the 
column. C5 was recovered by elution with a 50% 
glycerin solution in distilled water. The eluate was 
dialyzed intensively against 0.15 M NaCl, 0.02 M 
EDTA, 0.05 M l ACA (pH 7.2) and concentrated 
by ultrafiltration on PM 30 (Amicon). At this 
point of the purification scheme, C5 represented 
90% of the total protein and was contaminated 
with H, C4bp and albumin. 
3.2.2. Gel filtration 
C5 was separated from the impurities cited 
above by gel filtration on a Sephacryl S-300 (Phar- 
macia) column chromatography (1.5 cm x 
100 cm) equilibrated with 0.15 M NaCl, 0.02 M 
EDTA, 0.05 M 6ACA (pH 7.2). C4bp and H were 
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Fig. 2. Gel filtration of the post-phenyl-Sepharose 
CT-rich, C3-poor fraction (pool 1): (M) C5 
haemolytic activity. 
Fig, 4. Elution of complement component C3 from 
phenyl-Sepharose column chromatography: ( -) 
AIBD; (H) C3 haemolytic activity; (M) C5 









Fig. 3. SDS-PAGE of purified C5 and C3: (1) 7.5% 
acrylamide with 5% P-mercaptoethanol, (a) purified C3; 
(b) purified C5; (2) 5% acrylamide without ,& 
mercaptoethanol, (a)purified C3, (b) purified C5. 
eluted before C5 whereas albumin was eluted later 
(fig. 2). This procedure allowed the recovery of 
25 mg pure C5 giving a 34% recovery of initial C5. 
The haemolytic activity per mg of C5 was constant 
throughout the purification procedure (2 x 10’ 
CH 50 units/mg), indicating negligible inactivation 
of C5 during the course of purification. A typical 
C5 purification is illustrated by table 1. C5 was free 
of C3 (and of its degradation products), of H and 
C4bp, as demonstrated by haemolytic assay, 
haemagglutination assays and immunodiffusion. 
C5 exhibited a single band in SDS-PAGE of M, 
185000 and two bands under reducing conditions, 
LY M, 110000 and P III, 75000 (fig. 3). 
3.3. Purification of C3 
The C3-rich, CS-poor fraction (pool 2) could be 
further purified by phenyl-Sepharose affinity 
chromatography using the above conditions. A 
representative lution pattern is depicted in fig. 4. 
The first peak, corresponding to the void volume 
of the column, contained the majority of im- 
purities. C3 was retarded and appeared later. 
Material that bound firmly on phenyl-Sepharose 
was recovered by applying a glycerin gradient from 
O-50% (v/v) in distilled water. Contaminant C5 
appeared late in the gradient as shown by 
haemolytic monitoring of the column. 
C3 recovered in the retarded peak was free of 
C5, H, I and C4bp. Furthermore, C3 was free of 
inactivated form such as C3b-like [ll], as judged 
by immuno-electrophoresis in agar, that showed an 
homogeneous precipitin line, and by haemolytic 
criteria. C3b-like was recovered in the glycerin gra- 
dient since a protein of M, 185000 built of two 
chains M, 110000 and 75000, that reacted with the 
anti-C3c immuneserum, was recovered in the first 
peak of the gradient. This C3 fraction was devoid- 
ed of haemolytic activity. This procedure allowed 
the recovery of -20% of initial C3 (table 2). 
The remaining C5 obtained in the glycerin eluate 
could be purified by gel filtration as in section 
3.2.2. followed by a chromatography on a 
Sepharose anti-C3c to eliminate completely C3b- 
like contaminants. This procedure increased the 
recovery of C5 of 5-7% giving an overall yield of 
40-42% for this protein. 
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Table 1 
Summary of CS and C3 purifications 
December 1982 
CS mg Yield CS CHSO Yield C3 mg Yield C3 CHSO Yield 
Serum 80.0 100.00% 1.70x lo6 100.00% 675 100.00% 5.40x lo6 100.00% 
Euglobulin 60.0 15.00% 1.26x lo6 74.00% 386 57.00% 1.72x lo6 32.00% 
DEAE-Sephacel 
pool 1 35.4 44.25% 0.71 x lo6 41.70% 6.7 1.00% n.d. n.d. 
pool 2 7.6 9.50% 1.02x IO5 6.00% 214 31.70% 1.40x lo6 26.00% 
Pool 1 
Phenyl-Sepharose 
glycerin eluate 28.0 35.00% 0.58 x lo6 34.30070 - - 
Pool 2 
Phenyl-Sepharose 
retarded fraction - - 130 19.20% 1.05 x lo6 19.40% 
glycerin eluate 4.5 5.60% 0.11 x lo6 6.40% n.d. n.d. 0 
Total recovery 32.5 40.60% 0.69 x lo6 40.50% 130 19.20% 1.05 x lo6 19.40% 
aOne unit CHSO was the reciprocal of C-dilution that would Iyse 2.5 x lo8 cells 
4. DISCUSSION 
One of the major difficulties encountered during 
the purification of complement component C5 is 
its separation from C3. C3 and C5 have the same 
h4* and similar charge. C3 is at least IO-fold more 
concentrated than C5 and therefore is a major con- 
taminant in C5 purification. Generally, C3 and C5 
are separated by chromatography on hydrox- 
ylapatite [2, 51. This material is not easy to 
manipulate. 
In [12-141 about the hydrophobicity of C3, we 
demonstrated the usefulness of phenyl-Sepharose 
to prepare some fragments of C3. Here, we showed 
that phenyl-Sepharose is a powerful tool for the 
purification of C5 and of its major contaminant 
C3. Hydrophobic chromatography was first used 
in complement echnology in [5] with hexylamino- 
agarose resin. This resin was able to bind C3 and 
C5 but failed to separate the two components. 
On the phenyl-Sepharose resin in physiological 
conditions of ionic strength and pH, C3 was only 
retarded but C5 bound firmly to the resin. 
As an initial step for C5 purification, we chose 
the precipitation of the euglobulins. This precipi- 
tation allowed a good recovery of C5 (75%) but 
was less efficient for C3 (=50%). 
Using DEAE-Sephacel for ion-exchange chro- 
matographic resin allowed a nearly complete sepa- 
ration of C3 and C5, as found in [3] as well. The 
two linear-step gradient permitted us to obtain a 
considerable nrichment of C3 and C5, but H, that 
eluted before C5, trailed at a low level all along the 
elution of C5 and C3, and was a potent contami- 
nant for the two proteins. 
After phenyl-Sepharose chromatography, C5 
was contaminated by C4bp, H and albumin only. 
These proteins were easily removed by gel filtration 
on Sephacryl S-300. C4bp eluted in the void 
volume and appeared very pure. H eluted between 
C4bp and C5 exhibiting M, 300000, as found in 
]151. 
This four-step procedure allowed the recovery of 
= 35% of the initial C5 with a complete integrity of 
the haemolytic activity. In some cases, we observed 
the constant presence of a minute amount of 
albumin (detectable only by SDS-PAGE with 
,B-mercaptoethanol) even after a chromatography 
on con A-Sepharose. In view of C5 structural data 
[16] showing the presence of a free thiol group, it 
was postulated that albumin might complex C5 
through a disulfide bond as well as a-1-antitrypsin 
and IgA. This oxydation would be favoured by the 
concentration of C5 fractions during the isolating 
process. 
This paper revealed that phenyl-Sepharose was 
very efficient for the purification of C3. C3 was 
purified in 3 steps only but with a rather low yield 
compared to the method in [3]. The initial step of 
purification was the major cause of this fact. As it 
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was expected, phenyl-Sepharose was able to 
discriminate between C3- and C3b-like molecules. 
We showed the possibility to separate C3 from C3b 
by phenyl-Sepharose chromatography [131. C3b- 
like acquired the functional properties of C3b [I l] 
and exhibited an enhancement of hydrophobicity 
[17]. These results indicated that C.5 was certainly 
more hydrophobic than C3. This point is under 
investigation. 
This procedure allowed the rapid recovery of C3 
and CS at a very high degree of purity and free of 
other complement components. We checked the 
presence of H, I and C4bp. Moreover, we obtained 
some mg pure C4bp. C3 and C5 consisted of two 
polypeptide disulfide-linked chains of MI 110000 
and 75000, as shown [2, 51. 
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